Sagimet Biosciences Inc (SGMT)
4.325
+0.04
(+0.82%)
USD |
NASDAQ |
May 07, 15:35
Sagimet Biosciences Market Cap: 138.03M for May 7, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 06, 2024 | 136.91M |
May 03, 2024 | 137.87M |
May 02, 2024 | 142.02M |
May 01, 2024 | 131.17M |
April 30, 2024 | 124.46M |
April 29, 2024 | 135.00M |
April 26, 2024 | 129.57M |
April 25, 2024 | 125.10M |
April 24, 2024 | 133.08M |
April 23, 2024 | 136.59M |
April 22, 2024 | 128.61M |
April 19, 2024 | 127.97M |
April 18, 2024 | 126.70M |
April 17, 2024 | 129.89M |
April 16, 2024 | 133.40M |
April 15, 2024 | 145.53M |
April 12, 2024 | 154.14M |
April 11, 2024 | 166.59M |
April 10, 2024 | 161.48M |
April 09, 2024 | 169.46M |
April 08, 2024 | 171.70M |
April 05, 2024 | 169.46M |
April 04, 2024 | 173.93M |
April 03, 2024 | 173.29M |
April 02, 2024 | 167.23M |
Date | Value |
---|---|
April 01, 2024 | 166.91M |
March 28, 2024 | 172.97M |
March 27, 2024 | 182.87M |
March 26, 2024 | 166.91M |
March 25, 2024 | 166.59M |
March 22, 2024 | 143.93M |
March 21, 2024 | 148.40M |
March 20, 2024 | 145.53M |
March 19, 2024 | 142.97M |
March 18, 2024 | 128.29M |
March 15, 2024 | 128.93M |
March 14, 2024 | 137.87M |
March 13, 2024 | 148.32M |
March 12, 2024 | 159.16M |
March 11, 2024 | 174.79M |
March 08, 2024 | 183.40M |
March 07, 2024 | 205.73M |
March 06, 2024 | 212.75M |
March 05, 2024 | 192.97M |
March 04, 2024 | 199.35M |
March 01, 2024 | 192.01M |
February 29, 2024 | 195.52M |
February 28, 2024 | 203.81M |
February 27, 2024 | 235.71M |
February 26, 2024 | 229.65M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
51.06M
Minimum
Nov 13 2023
421.74M
Maximum
Jan 22 2024
192.82M
Average
168.33M
Median
Market Cap Benchmarks
Madrigal Pharmaceuticals Inc | 4.350B |
89bio Inc | 893.21M |
Viking Therapeutics Inc | 8.817B |
Akero Therapeutics Inc | 1.522B |
Arrowhead Pharmaceuticals Inc | 3.106B |
Market Cap Related Metrics
Price to Book Value | 1.516 |
Price | 4.325 |
Earnings Yield | -30.27% |